Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Cellegy to acquire nitroglycerin-based product for anorectal conditions

Nov. 6, 1997

KGF fragments from Chiron display wound-healing activity

Nov. 5, 1997

Lifecore reaches patient enrollment milestone in Intergel study

Oct. 30, 1997

Differin is equieffective but better tolerated than Retin A in patients with acne

Oct. 29, 1997

Apligraf comparable to autograft for donor site wounds

Oct. 29, 1997

VIMRxyn enters phase II for treatment of skin diseases

Oct. 27, 1997

Topical antiinflammatory activity of COX-2 inhibitors assessed

Oct. 27, 1997

ARS discloses new 5alpha-reductase inhibitors

Oct. 27, 1997

ADCON-L up for advisory committee review

Oct. 24, 1997

Encouraging preliminary results for finasteride in androgenic alopecia

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...